Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT03814356
PHASE1

Stimulant Therapy Targeted to Individualized Connectivity Maps to Promote ReACTivation of Consciousness

Sponsor: Massachusetts General Hospital

View on ClinicalTrials.gov

Summary

Phase 1 of the STIMPACT trial is an open label,dose-escalation,safety study of intravenous (IV) methylphenidate (MPH) therapy in patients with disorders of consciousness (DoC) caused by severe brain injuries.

Official title: Stimulant Therapy Targeted to Individualized Connectivity Maps to Promote ReACTivation of Consciousness - A Phase 1 Study

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

10

Start Date

2020-08-24

Completion Date

2026-06-30

Last Updated

2025-10-29

Healthy Volunteers

No

Interventions

DRUG

Methylphenidate

IV MPH

Locations (1)

Massachusetts General Hospital

Boston, Massachusetts, United States